Clinical application of blood biomarkers in cerebrovascular disease

References

• Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation113(10), e409–e449 (2006).
   PubMed Web of Science ®Google Scholar
• Jensen MB, Chacon MR, Sattin JA, Aleu A, Lyden PD. The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack. Neurologist14(4), 243–246 (2008).
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke40(1), 77–85 (2009).
   PubMed Web of Science ®Google Scholar
• Chalela JA, Kidwell CS, Nentwich LM et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet369(9558), 293–298 (2007).
   PubMed Web of Science ®Google Scholar
• Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology56(8), 1015–1020 (2001).
   PubMed Web of Science ®Google Scholar
• Frank R, Hargreaves R. Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov.2(7), 566–580 (2003).
   PubMed Web of Science ®Google Scholar
• Howes JM, Keen JN, Findlay JB, Carter AM. The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease. Diab. Vasc. Dis. Res.5(3), 205–212 (2008).
   PubMed Web of Science ®Google Scholar
• Foerch C, Montaner J, Furie KL, Ning MM, Lo EH. Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology73(5), 393–399 (2009).
   PubMed Web of Science ®Google Scholar
• Manolio T. Novel risk markers and clinical practice. N. Engl. J. Med.349(17), 1587–1589 (2003).
   PubMed Web of Science ®Google Scholar
• Whiteley W, Tseng MC, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke39(10), 2902–2909 (2008).
   PubMed Web of Science ®Google Scholar
• Laterza OF, Modur VR, Crimmins DL et al. Identification of novel brain biomarkers. Clin. Chem.52(9), 1713–1721 (2006).
   PubMed Web of Science ®Google Scholar
• Reynolds MA, Kirchick HJ, Dahlen JR et al. Early biomarkers of stroke. Clin. Chem.49(10), 1733–1739 (2003).
   PubMed Web of Science ®Google Scholar
• Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke37(10), 2508–2513 (2006).
   PubMed Web of Science ®Google Scholar
• Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology67(2), 203–210 (2006).
   PubMed Web of Science ®Google Scholar
• Herrmann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor. Neurol. Neurosci.21(3–4), 177–190 (2003).
   PubMed Web of Science ®Google Scholar
• Fassbender K, Schmidt R, Schreiner A et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J. Neurol. Sci.148(1), 101–105 (1997).
   PubMed Web of Science ®Google Scholar
• Anand N, Stead LG. Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc. Dis.20(4), 213–219 (2005).
   PubMed Web of Science ®Google Scholar
• Akpinar O, Geyik S, Acikalin A, Karakan Y, Tiryaki O. H-FABP in the early diagnosis of stroke. J. Neurol.256(11), 1922–1923 (2009).
   PubMed Web of Science ®Google Scholar
• Lescuyer P, Allard L, Hochstrasser DF, Sanchez JC. Heart-fatty acid-binding protein as a marker for early detection of acute myocardial infarction and stroke. Mol. Diagn.9(1), 1–7 (2005).
   PubMedGoogle Scholar
• Zimmermann-Ivol CG, Burkhard PR, Le Floch-Rohr J, Allard L, Hochstrasser DF, Sanchez JC. Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study. Mol. Cell. Proteomics3(1), 66–72 (2004).
   PubMed Web of Science ®Google Scholar
• Wunderlich MT, Hanhoff T, Goertler M et al. Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J. Neurol.252(6), 718–724 (2005).
   PubMed Web of Science ®Google Scholar
• Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem.49(10), 1752–1762 (2003).
   PubMed Web of Science ®Google Scholar
• Kanner AA, Marchi N, Fazio V et al. Serum S100β: a noninvasive marker of blood–brain barrier function and brain lesions. Cancer97(11), 2806–2813 (2003).
   PubMed Web of Science ®Google Scholar
• Stroick M, Fatar M, Ragoschke-Schumm A, Fassbender K, Bertsch T, Hennerici MG. Protein S-100B – a prognostic marker for cerebral damage. Curr. Med. Chem.13(25), 3053–3060 (2006).
   PubMed Web of Science ®Google Scholar
• Fazio V, Bhudia SK, Marchi N, Aumayr B, Janigro D. Peripheral detection of S100β during cardiothoracic surgery: what are we really measuring? Ann. Thorac. Surg.78(1), 46–52 (2004).
   PubMed Web of Science ®Google Scholar
• Foerch C, Wunderlich MT, Dvorak F et al. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke38(9), 2491–2495 (2007).
   PubMed Web of Science ®Google Scholar
• Delgado P, Alvarez Sabin J, Santamarina E et al. Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke37(11), 2837–2839 (2006).
   PubMed Web of Science ®Google Scholar
• Foerch C, Singer OC, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch. Neurol.62(7), 1130–1134 (2005).
   PubMed Web of Science ®Google Scholar
• Wunderlich MT, Wallesch CW, Goertler M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J. Neurol. Sci.227(1), 49–53 (2004).
   PubMed Web of Science ®Google Scholar
• Foerch C, Otto B, Singer OC et al. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke35(9), 2160–2164 (2004).
   PubMed Web of Science ®Google Scholar
• Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke28(10), 1956–1960 (1997).
   PubMed Web of Science ®Google Scholar
• Foerch C, du Mesnil de Rochemont R, Singer O et al. S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion. J. Neurol. Neurosurg. Psychiatry74(3), 322–325 (2003).
   PubMed Web of Science ®Google Scholar
• Foerch C, Curdt I, Yan B et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J. Neurol. Neurosurg. Psychiatry77(2), 181–184 (2006).
   PubMed Web of Science ®Google Scholar
• Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc. Dis.27(1), 37–41 (2009).
   PubMed Web of Science ®Google Scholar
• Tombul T, Atbas C, Anlar O. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. J. Clin. Neurosci.12(4), 429–434 (2005).
   PubMed Web of Science ®Google Scholar
• Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke37(7), 1798–1804 (2006).
   PubMed Web of Science ®Google Scholar
• Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. D-dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays. Stroke37(4), 1113–1115 (2006).
   PubMed Web of Science ®Google Scholar
• Haapaniemi E, Tatlisumak T. Is D-dimer helpful in evaluating stroke patients? A systematic review. Acta Neurol. Scand.119(3), 141–150 (2009).
   PubMed Web of Science ®Google Scholar
• Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc. Dis.27(3), 247–253 (2009).
   PubMed Web of Science ®Google Scholar
• Kang DW, Yoo SH, Chun S et al. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke40(5), 1653–1658 (2009).
   PubMed Web of Science ®Google Scholar
• Delgado P, Alvarez-Sabin J, Abilleira S et al. Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage. Neurology67(1), 94–98 (2006).
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Singh P. Is plasma fibrinogen useful in evaluating ischemic stroke patients?: why, how, and when. Stroke40(5), 1549–1552 (2009).
   PubMed Web of Science ®Google Scholar
• del Zoppo GJ, Levy DE, Wasiewski WW et al. Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke40(5), 1687–1691 (2009).
   PubMed Web of Science ®Google Scholar
• Turaj W, Slowik A, Dziedzic T et al. Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. J. Neurol. Sci.246(1–2), 13–19 (2006).
   PubMed Web of Science ®Google Scholar
• Danesh J, Lewington S, Thompson SG et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA294(14), 1799–1809 (2005).
   PubMed Web of Science ®Google Scholar
• Woodward M, Lowe GD, Campbell DJ et al. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke36(10), 2143–2147 (2005).
   PubMed Web of Science ®Google Scholar
• Castellanos M, Leira R, Serena J et al. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke35(7), 1671–1676 (2004).
   PubMed Web of Science ®Google Scholar
• Bongers TN, de Maat MP, van Goor ML et al. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke37(11), 2672–2677 (2006).
   PubMed Web of Science ®Google Scholar
• Sato M, Suzuki A, Nagata K, Uchiyama S. Increased von Willebrand factor in acute stroke patients with atrial fibrillation. J. Stroke Cerebrovasc. Dis.15(1), 1–7 (2006).
   PubMedGoogle Scholar
• McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery51(5), 1128–1134; discussion 1134–1125 (2002).
   PubMed Web of Science ®Google Scholar
• McColl BW, Allan SM, Rothwell NJ. Systemic infection, inflammation and acute ischemic stroke. Neuroscience158(3), 1049–1061 (2009).
   PubMed Web of Science ®Google Scholar
• Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke40(5), e380–e389 (2009).
   PubMed Web of Science ®Google Scholar
• Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic. Biol. Med.39(7), 841–852 (2005).
   PubMed Web of Science ®Google Scholar
• Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke37(2), 291–293 (2006).
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Schwaninger M, Cappelli R et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke36(6), 1316–1329 (2005).
   PubMed Web of Science ®Google Scholar
• Blann AD, Ridker PM, Lip GY. Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology? Stroke33(9), 2141–2143 (2002).
   PubMed Web of Science ®Google Scholar
• Pola R. Inflammatory markers for ischaemic stroke. Thromb. Haemost.101(5), 800–801 (2009).
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Kitagawa K, Hougaku H et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation104(1), 63–67 (2001).
   PubMed Web of Science ®Google Scholar
• Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke30(5), 981–985 (1999).
   PubMed Web of Science ®Google Scholar
• Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke33(10), 2459–2464 (2002).
   PubMed Web of Science ®Google Scholar
• Schwartz RS, Bayes-Genis A, Lesser JR, Sangiorgi M, Henry TD, Conover CA. Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers. J. Interv. Cardiol.16(3), 231–242 (2003).
   PubMedGoogle Scholar
• Montaner J, Molina CA, Monasterio J et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation107(4), 598–603 (2003).
   PubMed Web of Science ®Google Scholar
• Castellanos M, Leira R, Serena J et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke34(1), 40–46 (2003).
   PubMed Web of Science ®Google Scholar
• Tan KT, Blann AD. To stroke or not to stroke: is ICAM-1 or CRP the answer? Neurology60(12), 1884–1885 (2003).
   PubMed Web of Science ®Google Scholar
• Mocco J, Choudhri TF, Mack WJ et al. Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery48(4), 718–721 (2001).
   PubMed Web of Science ®Google Scholar
• Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S. Raised plasma oxidised LDL in acute cerebral infarction. J. Neurol. Neurosurg. Psychiatry74(3), 312–316 (2003).
   PubMed Web of Science ®Google Scholar
• Saito K, Suyama K, Nishida K, Sei Y, Basile AS. Early increases in TNF-α, IL-6 and IL-1 β levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett.206(2–3), 149–152 (1996).
   PubMed Web of Science ®Google Scholar
• Fassbender K, Rossol S, Kammer T et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci.122(2), 135–139 (1994).
   PubMed Web of Science ®Google Scholar
• Tarkowski E, Rosengren L, Blomstrand C et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke26(8), 1393–1398 (1995).
   PubMed Web of Science ®Google Scholar
• Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis. Atherosclerosis197(1), 326–332 (2008).
   PubMed Web of Science ®Google Scholar
• Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb. Haemost.101(5), 929–937 (2009).
   PubMed Web of Science ®Google Scholar
• Allard L, Burkhard PR, Lescuyer P et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin. Chem.51(11), 2043–2051 (2005).
   PubMed Web of Science ®Google Scholar
• Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke36(9), 1915–1919 (2005).
   PubMed Web of Science ®Google Scholar
• Ishigaki Y, Oka Y, Katagiri H. Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr. Opin. Lipidol.20(5), 363–369 (2009).
   PubMed Web of Science ®Google Scholar
• Cano CP, Bermudez VP, Atencio HE et al. Increased serum malondialdehyde and decreased nitric oxide within 24 hours of thrombotic stroke onset. Am. J. Ther.10(6), 473–476 (2003).
   PubMedGoogle Scholar
• Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N, Tataroglu C. Oxidative stress in acute ischemic stroke. J. Clin. Neurosci.14(11), 1062–1066 (2007).
   PubMed Web of Science ®Google Scholar
• Pikula A, Boger RH, Beiser AS et al. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study. Stroke40(9), 2959–2964 (2009).
   PubMed Web of Science ®Google Scholar
• Wanby P, Teerlink T, Brudin L et al. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis185(2), 271–277 (2006).
   PubMed Web of Science ®Google Scholar
• Makikallio AM, Makikallio TH, Korpelainen JT et al. Natriuretic peptides and mortality after stroke. Stroke36(5), 1016–1020 (2005).
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N. Engl. J. Med.350(7), 655–663 (2004).
   PubMed Web of Science ®Google Scholar
• Sviri GE, Shik V, Raz B, Soustiel JF. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir. (Wien.)145(10), 851–860; discussion 860 (2003).
   PubMed Web of Science ®Google Scholar
• Cucchiara BL, Messe SR, Sansing L et al. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke40(7), 2332–2336 (2009).
   PubMed Web of Science ®Google Scholar
• Gorelick PB. Lipoprotein-associated phospholipase A2 and risk of stroke. Am. J. Cardiol.101(12A), 34F–40F (2008).
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Starkman S, Teal P et al. Serum calcium as prognosticator in ischemic stroke. Stroke39(8), 2231–2236 (2008).
   PubMed Web of Science ®Google Scholar
• Na N, Ouyang J, Taes YE, Delanghe JR. Serum free hemoglobin concentrations in healthy individuals are related to haptoglobin type. Clin. Chem.51(9), 1754–1755 (2005).
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA293(13), 1653–1662 (2005).
   PubMed Web of Science ®Google Scholar
• Huang P, Lo LH, Chen YC, Lin RT, Shiea J, Liu CK. Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke. J. Neurol.256(4), 625–631 (2009).
   PubMed Web of Science ®Google Scholar
• Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT. Novel diagnostic test for acute stroke. Stroke35(1), 57–63 (2004).
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Blessing R, Floyd J, White WD, Lynch JR. Panel of biomarkers predicts stroke. Ann. NY Acad. Sci.1053, 30 (2005).
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin. Chem.49(1), 1–6 (2003).
   PubMed Web of Science ®Google Scholar
• Vanni S, Polidori G, Pepe G et al. Use of biomarkers in triage of patients with suspected stroke. J. Emerg. Med. (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Sibon I, Rouanet F, Meissner W, Orgogozo JM. Use of the Triage Stroke Panel in a neurologic emergency service. Am. J. Emerg. Med.27(5), 558–562 (2009).
   PubMed Web of Science ®Google Scholar
• Allard L, Lescuyer P, Burgess J et al. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics4(8), 2242–2251 (2004).
   PubMed Web of Science ®Google Scholar
• Montaner J, Perea-Gainza M, Delgado P et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke39(8), 2280–2287 (2008).
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Di Sciacca R, Di Raimondo D et al. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: Relationship with TOAST subtype, outcome and infarct site. J. Neuroimmunol.215(1–2), 84–89 (2009).
   PubMed Web of Science ®Google Scholar
• Xu H, Tang Y, Liu DZ et al. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J. Cereb. Blood Flow Metab.28(7), 1320–1328 (2008).
   PubMed Web of Science ®Google Scholar
• Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke35(6), 1421–1425 (2004).
   PubMed Web of Science ®Google Scholar
• Serena J, Blanco M, Castellanos M et al. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke36(9), 1921–1926 (2005).
   PubMed Web of Science ®Google Scholar
• Counsell C, Dennis M, McDowall M. Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J. Neurol. Neurosurg. Psychiatry75(3), 401–405 (2004).
   PubMed Web of Science ®Google Scholar
• Castillo J, Alvarez-Sabín J, Martínez-Vila E, Montaner J, Sobrino T, Vivancos J; MITICO Study Investigators. Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J. Neurol.256(2), 217–224 (2009)
   PubMed Web of Science ®Google Scholar
• Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA273(18), 1421–1428 (1995).
   PubMed Web of Science ®Google Scholar
• Golledge J, Siew DA. Identifying the carotid ‘high risk’ plaque: is it still a riddle wrapped up in an enigma? Eur. J. Vasc. Endovasc. Surg.35(1), 2–8 (2008).
   PubMed Web of Science ®Google Scholar
• Mannheim D, Herrmann J, Versari D et al. Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques. Stroke39(5), 1448–1455 (2008).
   PubMed Web of Science ®Google Scholar
• Eldrup N, Gronholdt ML, Sillesen H, Nordestgaard BG. Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation114(17), 1847–1854 (2006).
   PubMed Web of Science ®Google Scholar
• Rost NS, Wolf PA, Kase CS et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke32(11), 2575–2579 (2001).
   PubMed Web of Science ®Google Scholar
• van Dijk EJ, Prins ND, Vermeer SE et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation112(6), 900–905 (2005).
   PubMed Web of Science ®Google Scholar
• Hacke W, Warach S. Diffusion-weighted MRI as an evolving standard of care in acute stroke. Neurology54(8), 1548–1549 (2000).
   PubMed Web of Science ®Google Scholar
• Pettigrew LC, Kasner SE, Gorman M, Atkinson RP, Funakoshi Y, Ishibashi H. Effect of arundic acid on serum S-100β in ischemic stroke. J. Neurol. Sci.251(1–2), 57–61 (2006).
   PubMed Web of Science ®Google Scholar
• Lynch JR, Wang H, McGirt MJ et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke36(9), 2024–2026 (2005).
   PubMed Web of Science ®Google Scholar
• Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin. Neurol. Neurosurg.108(6), 558–563 (2006).
   PubMed Web of Science ®Google Scholar
• Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann. Clin. Biochem.34(Pt 4), 366–370 (1997).
   PubMed Web of Science ®Google Scholar
• Olivot JM, Labreuche J, Aiach M, Amarenco P. Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke35(8), 1946–1951 (2004).
   PubMed Web of Science ®Google Scholar
• DeGraba TJ, Siren AL, Penix L et al. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke29(7), 1405–1410 (1998).
   PubMed Web of Science ®Google Scholar
• Hill MD, Jackowski G, Bayer N, Lawrence M, Jaeschke R. Biochemical markers in acute ischemic stroke. CMAJ162(8), 1139–1140 (2000).
   PubMed Web of Science ®Google Scholar